Intercept Pharmaceuticals reported $230.08M in Current Liabilities for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 125.63M 9.06M
Acorda Therapeutics ACOR:US USD 37.95M 4.07M
Alnylam Pharmaceuticals ALNY:US USD 767.92M 4.88M
Amarin AMRN:US USD 287.36M 74.22M
Amgen AMGN:US USD 15.69B 1.36B
Arrowhead Research ARWR:US USD 122.01M 16.84M
AstraZeneca AZN:LN USD 26.29B 1.44B
Biogen BIIB:US USD 3.27B 653.6M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Enanta Pharmaceuticals ENTA:US USD 23M 6.83M
Esperion Therapeutics ESPR:US USD 92.31M 9.96M
Galectin Therapeutics GALT:US USD 9.59M 1.3M
Gilead Sciences GILD:US USD 11.24B 814M
GlaxoSmithKline GSK:LN GBP 22.81B 1.86B
Intercept Pharmaceuticals ICPT:US USD 230.08M 8.49M
Moderna Inc MRNA:US USD 4.92B 1.88B
Neurocrine Biosciences NBIX:US USD 537.7M 52.6M
Novartis NOVN:VX USD 28.66B 496M
Ptc Therapeutics PTCT:US USD 406.24M 13.84M
Regeneron Pharmaceuticals REGN:US USD 3.85B 969.9M
Sangamo Biosciences SGMO:US USD 111.71M 10.65M
Sarepta Therapeutics SRPT:US USD 619.6M 16.69M
Vertex Pharmaceuticals VRTX:US USD 2.43B 178.7M
YTE INCY:US USD 1.16B 150.48M